ARC (AA 2-18) Antikörper
-
- Target
- ARC
-
Bindungsspezifität
- AA 2-18
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Reacts with the human, mouse, and rat ARC.
- Aufreinigung
- Purified
- Immunogen
- Peptide corresponding to aa 2-18 of human ARC.
- Isotyp
- IgG
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(2 μg/mL)
Positive control: HeLa cells - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Dilute in PBS or medium that is identical to that used in the assay system.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- ARC
- Synonyme
- activity regulated cytoskeleton associated protein antikoerper, Arc antikoerper
- Hintergrund
-
A novel CARD domain-containing protein was recently identified and designated ARC (apoptosis repressor with CARD). ARC interacts with caspase-2 and -8 and inhibits enzymatic activity of caspase-8. ARC suppresses apoptosis induced by cell death adapters FADD and TRADD and by cell death receptors Fas, TNFR-1, and DR3. The mRNA of ARC is primarily expressed in skeletal muscle and cardiac tissue.
Nucleolar protein 3 Apoptosis repressor with CARD Muscle-enriched cytoplasmic protein, Myp Nucleolar protein of 30 kDa, Nop30 Gene name: NOL3, ARC, NOP, FCM, - Gen-ID
- 8996
- UniProt
- O60936
-